🔬 WHAT THEY DID
Study design: Narrative review and PRISMA-guided synthesis of 6 cohort studies.
Who was studied: 6 pooled studies included 116 patients with copper-deficiency blood problems (from Hungary, US, UK, and Japan).
How long: Literature published from 2000 to 2025.
What they measured: Blood count changes (anemia, low white cells, low platelets), bone marrow findings, nerve effects, and response to copper treatment.
Funding: Japanese government research grants. One author disclosed research funding, lecture fees, and donations from pharmaceutical companies.
📊 WHAT THEY FOUND
Copper is needed to move iron and to keep blood cell production running, so a shortage shows up in the blood first.
Main finding 1: Copper powers two enzymes - ceruloplasmin (in the blood) and hephaestin (in the gut lining) - that switch iron into the form it needs to bind its transport protein. Ceruloplasmin carries 70-90% of the copper circulating in the blood, so when copper is low, iron can’t be moved efficiently and anemia develops.
Main finding 2: The classic picture is anemia together with low neutrophils (a type of white blood cell), a combination often misread as B12 deficiency or a bone-marrow disorder (MDS). The anemia can have small, normal, or large red cells; in the authors' own patient series the median red-cell size (MCV) was 101 fL.
Main finding 3: High-dose zinc is a leading cause. It traps copper in the gut. In the authors' hospital series of 15 patients, 65% of cases traced to prescribed zinc. Other major causes were gut or weight-loss surgery and long-term tube or IV feeding.
Main finding 4: It's largely reversible. Most blood problems corrected with copper (in one study, 7 of 8 patients reached remission within 3–4 weeks), though nerve damage from a prolonged shortage may not fully recover.
⚠️ LIMITATIONS
It pools mostly small, retrospective case series (5–40 patients each), not controlled trials. It shows patterns and treatment responses, not proof from randomized studies.
The studies didn't report results by sex, and the review doesn't say how many patients were women.
Almost everyone studied had a specific trigger (high-dose zinc, gut surgery, tube/IV feeding, dialysis, or Wilson's disease), so it doesn’t tell us how common copper deficiency is in otherwise healthy women.
💡 BOTTOM LINE
Copper deficiency is a treatable, and often-missed cause of anemia and low blood counts that can look like a B12 problem or bone-marrow disease. It mainly turns up in people with a clear trigger, especially high-dose zinc or gut surgery, and most cases bounce back once copper is restored.
🔗 MORE TO EXPLORE
